Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma.
Tucci
Alessandra
A
Cerqui
Elisa
E
Ungari
Marco
M
Ferrari
Samantha
S
Baushi
Liliana
L
Facchetti
Fabio
F
Rossi
Giuseppe
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D055815:Young Adult
D003520:Cyclophosphamide; D011239:Prednisolone